Skip to content
PatentBrief
Get alertsTop ↑

How Andrew Moyer Learned to Mass-Produce Penicillin

This 1948 patent details a method for growing the mold Penicillium in large vats using a corn steep liquor medium, which enabled the mass production of life-saving antibiotics.

Granted 1948ExpiredExpired 1965Owned by US Department of Agriculture USDAInvented by Andrew J Moyer

Original patent title: “Method for production of penicillin

Plain-English explanation by SahiLast reviewed · June 15, 2026

This 1948 patent details a method for growing the mold Penicillium in large vats using a corn steep liquor medium, which enabled the mass production of life-saving antibiotics. Granted to US Department of Agriculture USDA in 1948 with 13 forward citations.

Key facts

Patent numberUS 2442141
StatusExpired
FieldBiotech & Medicine
AssigneeUS Department of Agriculture USDA
InventorAndrew J Moyer
Filed1945
Granted1948
Times cited13
LitigationNone on record
Value · $8K$25KMinimal

Coverage

What does this patent actually cover?

The patent describes a method for increasing the yield of penicillin by using a specific culture medium containing corn steep liquor and lactose. By submerged fermentation in aerated tanks, the mold Penicillium chrysogenum produces significantly higher concentrations of the antibiotic than previous surface-growth methods. This process allowed the transition from slow, small-scale laboratory production to industrial-scale manufacturing.

The gap

What does this patent NOT cover?

  • Does not cover the discovery of penicillin itself
  • Does not cover the medical application or dosage of penicillin
  • Does not cover synthetic methods for creating penicillin-like compounds

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

What made this novel

The innovation was the use of corn steep liquor as a nutrient-rich base for the mold, which acted as a catalyst to drastically boost the production of the antibiotic during fermentation.

Method for production of penic…(Primary claim)biotechpharmaceutical

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Industrial fermentation tanks for pharmaceutical production

02

Large-scale antibiotic manufacturing facilities

Why it matters

The bigger picture

This invention was critical for scaling up penicillin production during and after World War II. It transformed a rare, expensive laboratory curiosity into a widely available medicine, effectively launching the modern antibiotic era.

Filed

May 11, 1945

Granted

May 25, 1948

Market context

Who's building on this

Companies in this space

Major pharmaceutical companies like Pfizer and Merck built their early antibiotic manufacturing capabilities on the foundation of this submerged fermentation process. Today, the principles of large-scale bioreactor fermentation remain the standard for producing complex biological drugs.

Market impact

This patent enabled the rapid commercialization of antibiotics, saving millions of lives and creating the modern pharmaceutical industry. It shifted the focus of medicine toward mass-produced, standardized chemical treatments for infectious diseases.

Claim 1 — Plain English

What this patent covers

The patent describes a method for increasing the yield of penicillin by using a specific culture medium containing corn steep liquor and lactose. By submerged fermentation in aerated tanks, the mold Penicillium chrysogenum produces significantly higher concentrations of the antibiotic than previous surface-growth methods. This process allowed the transition from slow, small-scale laboratory production to industrial-scale manufacturing.

The clever bit

The innovation was the use of corn steep liquor as a nutrient-rich base for the mold, which acted as a catalyst to drastically boost the production of the antibiotic during fermentation.

What it does not cover

  • Does not cover the discovery of penicillin itself
  • Does not cover the medical application or dosage of penicillin
  • Does not cover synthetic methods for creating penicillin-like compounds

Patent timeline

Filing

Application submitted to the patent office

Publication

Application published, typically 18 months after filing

Grant

Patent officially issued

PatentBrief Score

Impact Score

Early stage

Citation count

23/40

Moderately cited

Claim breadth

0/20

Narrow claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

0/20

Older than 20 years

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Minimal

$8K$25K

Midpoint $15K · expired or expiring · industry ×1.6

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Citations

Patent lineage

Cites earlier patents

2

earlier patents this invention cites as foundations

View prior art →

Cited by later patents

13

later patents that build on this invention

View patents →

Cite this patent

Moyer, A. J. (1948). How Andrew Moyer Learned to Mass-Produce Penicillin (U.S. Patent No. 2,442,141). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/2442141/vitamin-b12-isolation

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US2442141"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary

Common Questions

Frequently Asked Questions

What does How Andrew Moyer Learned to Mass-Produce Penicillin cover?

This 1948 patent details a method for growing the mold Penicillium in large vats using a corn steep liquor medium, which enabled the mass production of life-saving antibiotics.

Who owns patent US 2442141?

US Department of Agriculture USDA owns this patent, granted in 1948.

When does this patent expire?

This patent has expired and is now in the public domain — anyone can use the invention freely.

What is patent US 2442141 cited by?

This patent has been cited by 13 later patents that build on its ideas.

What problem does this patent solve?

This invention was critical for scaling up penicillin production during and after World War II. It transformed a rare, expensive laboratory curiosity into a widely available medicine, effectively launching the modern antibiotic era.

What does this patent NOT cover?

Does not cover the discovery of penicillin itself

Patent monitoring

Get notified when US Department of Agriculture USDA files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: June 15, 2026 · PatentBrief is not a law firm and this is not legal advice.